Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Longda Xinke Biological Pharmaceutical is a biotechnology company based in Hangzhou, China, specializing in the development and large-scale production of industrial and feed-grade enzymes. Established in 2004, the company utilizes advanced microbial fermentation and protein engineering technologies to manufacture products such as phytase, xylanase, and cellulase. These enzymatic solutions are primarily designed for the animal health and nutrition sectors to improve feed conversion rates and reduce environmental impact. While the company's name includes pharmaceutical terminology, its core business is centered on agricultural biotechnology and bio-enzyme engineering. The firm operates modern manufacturing facilities and serves both domestic Chinese and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Longda Xinke Biological Pharmaceutical.